These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35235193)
1. Addition time plays a major role in the inhibitory effect of chitosan on the production of Pseudomonas aeruginosa virulence factors. Kašparová P; Boková S; Rollová M; Paldrychová M; Vaňková E; Lokočová K; Michailidu J; Maťátková O; Masák J Braz J Microbiol; 2022 Jun; 53(2):535-546. PubMed ID: 35235193 [TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa Van Laar TA; Esani S; Birges TJ; Hazen B; Thomas JM; Rawat M mSphere; 2018 Apr; 3(2):. PubMed ID: 29669887 [No Abstract] [Full Text] [Related]
3. Anti-Virulence Potential of a Chionodracine-Derived Peptide against Multidrug-Resistant Artini M; Imperlini E; Buonocore F; Relucenti M; Porcelli F; Donfrancesco O; Tuccio Guarna Assanti V; Fiscarelli EV; Papa R; Selan L Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362282 [No Abstract] [Full Text] [Related]
4. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor. Furiga A; Lajoie B; El Hage S; Baziard G; Roques C Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774 [TBL] [Abstract][Full Text] [Related]
5. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277 [TBL] [Abstract][Full Text] [Related]
6. Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa. Hwang HJ; Choi H; Hong S; Moon HR; Lee JH Microbiol Spectr; 2021 Oct; 9(2):e0024921. PubMed ID: 34494853 [TBL] [Abstract][Full Text] [Related]
7. Transcriptome Analysis of Pseudomonas aeruginosa Biofilm Infection in an Harrington NE; Littler JL; Harrison F Appl Environ Microbiol; 2022 Feb; 88(3):e0178921. PubMed ID: 34878811 [TBL] [Abstract][Full Text] [Related]
8. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles. García-Lara B; Saucedo-Mora MÁ; Roldán-Sánchez JA; Pérez-Eretza B; Ramasamy M; Lee J; Coria-Jimenez R; Tapia M; Varela-Guerrero V; García-Contreras R Lett Appl Microbiol; 2015 Sep; 61(3):299-305. PubMed ID: 26084709 [TBL] [Abstract][Full Text] [Related]
10. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Smith S; Waters V; Jahnke N; Ratjen F Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436 [TBL] [Abstract][Full Text] [Related]
11. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986 [TBL] [Abstract][Full Text] [Related]
12. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model. Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568 [TBL] [Abstract][Full Text] [Related]
13. Antibiotics Enhance Prevention and Eradication Efficacy of Cathodic-Voltage-Controlled Electrical Stimulation against Titanium-Associated Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms. Canty MK; Hansen LA; Tobias M; Spencer S; Henry T; Luke-Marshall NR; Campagnari AA; Ehrensberger MT mSphere; 2019 May; 4(3):. PubMed ID: 31043516 [TBL] [Abstract][Full Text] [Related]
14. Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa. van Tilburg Bernardes E; Charron-Mazenod L; Reading DJ; Reckseidler-Zenteno SL; Lewenza S Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223377 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of chitosan oligosaccharide-capped gold nanoparticles as an effective antibiofilm drug against the Pseudomonas aeruginosa PAO1. Khan F; Lee JW; Manivasagan P; Pham DTN; Oh J; Kim YM Microb Pathog; 2019 Oct; 135():103623. PubMed ID: 31325574 [TBL] [Abstract][Full Text] [Related]
17. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants. Silva E; Monteiro R; Grainha T; Alves D; Pereira MO; Sousa AM Front Cell Infect Microbiol; 2020; 10():441. PubMed ID: 32974221 [TBL] [Abstract][Full Text] [Related]
18. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT. Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975 [TBL] [Abstract][Full Text] [Related]